OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Neurodevelopmental Pathways in Brain Tumors
Rachel Naomi Curry, Stacey M. Glasgow
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

How can same-gene mutations promote both cancer and developmental disorders?
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Science Advances (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 46

Neurodevelopmental disorders and cancer networks share pathways, but differ in mechanisms, signaling strength, and outcome
Bengi Ruken Yavuz, M. Kaan Arici, Habibe Cansu Demirel, et al.
npj Genomic Medicine (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 24

The TGF-β Family in Glioblastoma
Irene Golán‐Cancela, Laia Caja
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1067-1067
Open Access | Times Cited: 13

Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production
Ella Perrault, Jack Shireman, Eunüs S. Ali, et al.
Science Advances (2023) Vol. 9, Iss. 20
Open Access | Times Cited: 18

Neurodevelopmental disorders, immunity, and cancer are connected
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
iScience (2022) Vol. 25, Iss. 6, pp. 104492-104492
Open Access | Times Cited: 25

Applications of organoid technology to brain tumors
Jie Wen, Fangkun Liu, Quan Cheng, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 10, pp. 2725-2743
Open Access | Times Cited: 13

Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma
D. Johns, Richard J. Williams, Craig M. Smith, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 4

Brain development and bioenergetic changes
Arjun Rajan, Ryann M. Fame
Neurobiology of Disease (2024) Vol. 199, pp. 106550-106550
Open Access | Times Cited: 4

A fetal oncogene NUAK2 is an emerging therapeutic target in glioblastoma
Hanhee Jo, Aneesh Dalvi, Wenqi Yang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

The role of lncRNAs in the interplay of signaling pathways and epigenetic mechanisms in glioma
Can Bora Yildiz, Jian Du, K. Naga Mohan, et al.
Epigenomics (2025) Vol. 17, Iss. 2, pp. 125-140
Closed Access

Multifunctional Docetaxel Cholesterol‐Polyethylene Glycol Co‐Modified Poly (N‐Butyl) Cyanoacrylate Nanoparticles for Brain Tumor Therapy
Xiao Hu, Feifei Yang, Yonghong Liao, et al.
Drug Development Research (2025) Vol. 86, Iss. 2
Closed Access

Natural compounds as regulators of miRNAs: exploring a new avenue for treating brain cancer
Ahmed S. Doghish, Walaa A. El‐Dakroury, Ahmed I. Abulsoud, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access

Brain cancer: Current and new drug delivery systems
Gaurisha Alias Resha Ramnath Naik, Amrita Arup Roy, Namdev Dhas, et al.
Elsevier eBooks (2025), pp. 113-139
Closed Access

Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets
Iga Kołodziejczak-Guglas, Renan Simões, Emerson de Souza Santos, et al.
Cell Genomics (2025), pp. 100851-100851
Open Access

Gene regulatory networks analysis for the discovery of prognostic genes in gliomas
Pedro Marçal Barcelos, Igor Salerno Filgueiras, Adriel Leal Nóbile, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Neuronal IL-17 controls Caenorhabditis elegans developmental diapause through CEP-1/p53
Abhishiktha Godthi, Sehee Min, Srijit Das, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 12
Open Access | Times Cited: 3

Harnessing the role of aberrant cell signaling pathways in glioblastoma multiforme: a prospect towards the targeted therapy
S. M. Murshid Hasan, Zimam Mahmud, Mahmud Hossain, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3

Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma
Danijela Drakulić, Marija Schwirtlich, Isidora Petrović, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2530-2530
Open Access | Times Cited: 15

Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma
Donald W. Coulter, Yashpal S. Chhonker, Devendra Kumar, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2

Gliomas: a reflection of temporal gliogenic principles
Caitlin Sojka, Steven A. Sloan
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2

The tumor suppressor CREBBP and the oncogene MYCN cooperate to induce malignant brain tumors in mice
Melanie Schoof, Gefion Dorothea Epplen, Carolin Walter, et al.
Oncogenesis (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 5

Identification of glioblastoma stem cell-associated lncRNAs using single-cell RNA sequencing datasets
Rasmani Hazra, Raditya Utama, Payal Naik, et al.
Stem Cell Reports (2023) Vol. 18, Iss. 11, pp. 2056-2070
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top